Prognosis of patients with multiple sclerosis associated with uveitis.

Background: Uveitis may be associated with multiple sclerosis (MS) in 1% of cases. Prognosis of this association remains unknown.

Methods: We conducted a retrospective analysis in a cohort of 41 patients with MS (34 relapsing-remitting MS, and 7 secondary progressive MS) matched with 123 controls (MS without uveitis) followed in Department of Neurology, Pitié Salpêtrière Hospital, Paris.

Impact of adult cochlear implantation on the partner relationship: a conceptual framework informed by cochlear implant recipient and partner perceptions.

Purpose: (1) To understand the impact of adult cochlear implantation on the partner relationship, as perceived by adult cochlear implant (CI) recipients and their intimate partners. (2) To generate a conceptual framework for guiding future research and clinical adult cochlear implantation interventions.

Method: Concept mapping, a participatory, mixed-method approach, was used for data collection, analysis and interpretation.

Meaningful life changes following hearing aid use: a qualitative user perspective.

Objective: This study aimed to explore meaningful life changes due to hearing aid use in adult users.

Design: A cross-sectional survey design was used with open-ended questions analysed using inductive qualitative content analysis.

Study Sample: US-based adult hearing aid users (n = 653) from the Hearing Tracker website community and Lexie Hearing database.

Impact of paediatric cochlear implantation on family life: a conceptual framework informed by parents.

Purpose: While the impact of paediatric cochlear implantation on parents and siblings are recognised, limited evidence exists regarding the effect of paediatric cochlear implantation on the entire family life (e.g., routine interactions, family activities).

Evidence of disease activity during pregnancy and post-partum in MS patients treated with high-efficacy therapies.

Background: Multiple sclerosis (MS) predominantly affects women of childbearing age. Due to the risk of teratogenicity, women with active multiple sclerosis (MS) who require high-efficacy therapies (HET) may need to discontinue treatment during pregnancy. Fingolimod and Natalizumab withdrawal increases the risk of disease reactivation, a risk not commonly associated with anti-CD20 therapies.